Zepbound® and Mounjaro® are brand-name medications that contain tirzepatide, a first-in-class dual GIP and GLP-1 receptor agonist. These injectable medications work by targeting two natural hormones that regulate blood sugar, appetite, and fat metabolism.
Zepbound® is FDA-approved for chronic weight management in adults with obesity or overweight and at least one related health condition.
Mounjaro® is FDA-approved for type 2 diabetes and is often prescribed off-label for weight loss based on clinical judgment.
Tirzepatide has shown greater weight loss outcomes than semaglutide (Ozempic®, Wegovy®) in clinical studies and is administered once weekly by injection.
*Final price to patient will depend on medication dosage and membership plan purchase.
✅ Adults with a BMI ≥30, or ≥27 with conditions like PCOS, insulin resistance, or prediabetes
✅ Those who don’t qualify for—or can’t afford—brand-name GLP-1s
✅ Patients seeking medically managed weight loss with ongoing support
✅ Anyone committed to sustainable, health-focused fat loss
Complete a secure online consultation
Your provider evaluates your goals, history & labs
If appropriate, you’ll receive a Zepbound / Mounjaro prescription
All medications come with full instructions
Track your results and get support inside our AI-powered app
Customer was compensated for their opinion. Results have not been independently verified. Individual results will vary.
Patients prescribed Zepbound® or Mounjaro® and following a comprehensive plan may see:
💊 Zepbound / Mounjaro
Starting at $349/month — includes prescription, shipping, and refill coordination.
💡 Pair it with our $199/month membership for full medical support, progress tracking, and coaching.
✅ Our Guarantee: Follow your plan or we refund your monthly membership fee. (Medication cost is non-refundable.)
Getting access to Zepbound / Mounjaro is simple, safe, and fast.
👉 Take the 60-second quiz
👉 Match with a provider
👉 Get personalized treatment shipped to your door
Both contain tirzepatide.
Zepbound® is FDA-approved for weight loss.
Mounjaro® is FDA-approved for type 2 diabetes but may be prescribed off-label for weight management.
Tirzepatide activates two hormones—GIP and GLP-1—leading to better appetite control, slower digestion, enhanced insulin release, and increased fat loss.
Both Zepbound® and Mounjaro® are once-weekly subcutaneous injections. You self-inject at home with a prefilled pen, on the same day each week.
Many patients notice reduced appetite within the first 1–2 weeks and begin losing weight consistently after 3–4 weeks. Full results build over several months with continued use and lifestyle support.
Yes.
Zepbound® is FDA-approved for chronic weight management.
Mounjaro® is FDA-approved for type 2 diabetes and may be prescribed for weight loss at a provider’s discretion.
The list price is ~$1,060/month without insurance.
Manufacturer savings cards and insurance may significantly reduce out-of-pocket costs. Currently, it is $349 for a 2.5mg vial, $499 for a 5mg vial, for a one-month prescription from LillyDirect self-pay.
Common side effects include nausea, constipation, fatigue, and mild GI upset—usually temporary. Your provider will monitor your response and adjust the dose if needed.
In head-to-head clinical trials, tirzepatide resulted in greater average weight loss and improved insulin sensitivity. However, individual responses vary. Your provider will recommend what’s best for your needs and tolerance.
Zepbound® and Mounjaro® are FDA-approved prescription medications that contain tirzepatide, a dual GIP and GLP-1 receptor agonist. These medications are intended for use under the supervision of a licensed medical provider.
Zepbound® is approved for chronic weight management in adults with a BMI ≥30, or ≥27 with a related condition like hypertension, type 2 diabetes, or sleep apnea.
Mounjaro® is approved for blood sugar control in adults with type 2 diabetes and may be prescribed off-label for weight loss.
Tirzepatide is administered once weekly and requires ongoing provider supervision to monitor for side effects, adjust dosing, and assess progress.
Important Warnings: Do not use tirzepatide if you have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2). Not for use in type 1 diabetes or during pregnancy. Notify your provider if you experience severe abdominal pain, vision changes, or signs of allergic reaction.
Always read the full prescribing information, Medication Guide, and consult your provider for personalized medical advice.
© 2025 Miami Weight Loss All rights reserved. Miami Weight Loss is a MedspaCircle.com Network
The content/images on this website are not a guarantee of individual results. Individual results may vary. The information provided on this site is for general informational purposes only, and does not replace the need for a formal consultation with a healthcare provider before undergoing a procedure or skin care treatment.
